5-hydroxymebendazole has been researched along with aminomebendazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellanos-Gonzalez, A; Fan, E; Geiger, JA; He, P; Johnson, SM; Larson, ET; Maly, DJ; Merritt, EA; Ojo, KK; Parsons, M; Van Voorhis, WC; Verlinde, CL; White, AC; Zhang, Z | 1 |
| Nakagawa, T; Nishimuta, H; Nomura, N; Yabuki, M | 1 |
2 other study(ies) available for 5-hydroxymebendazole and aminomebendazole
| Article | Year |
|---|---|
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.
Topics: Benzimidazoles; Cryptosporidium parvum; Drug Design; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-abl; Protozoan Proteins; Solubility; src-Family Kinases; Structure-Activity Relationship; Toxoplasma | 2012 |
Significance of reductive metabolism in human intestine and quantitative prediction of intestinal first-pass metabolism by cytosolic reductive enzymes.
Topics: Cytosol; Haloperidol; Humans; Intestinal Mucosa; Intestines; Liver; Mebendazole; NADP; Oxidation-Reduction; Piperazines; Thiazoles | 2013 |